Guizhou Xinbang Pharmaceutical Co (SZSE:002390) Total Liabilities : ¥2,016 Mil (As of Mar. 2025)

View and export this data going back to 2010. Start your Free Trial

What is Guizhou Xinbang Pharmaceutical Co Total Liabilities?

Guizhou Xinbang Pharmaceutical Co's Total Liabilities for the quarter that ended in Mar. 2025 was ¥2,016 Mil.

Guizhou Xinbang Pharmaceutical Co's quarterly Total Liabilities increased from Sep. 2024 (¥1,799.70 Mil) to Dec. 2024 (¥2,008.42 Mil) and increased from Dec. 2024 (¥2,008.42 Mil) to Mar. 2025 (¥2,015.63 Mil).

Guizhou Xinbang Pharmaceutical Co's annual Total Liabilities declined from Dec. 2022 (¥2,728.60 Mil) to Dec. 2023 (¥2,102.89 Mil) and declined from Dec. 2023 (¥2,102.89 Mil) to Dec. 2024 (¥2,008.42 Mil).

Guizhou Xinbang Pharmaceutical Co Total Liabilities Historical Data

The historical data trend for Guizhou Xinbang Pharmaceutical Co's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Guizhou Xinbang Pharmaceutical Co Total Liabilities Chart

Guizhou Xinbang Pharmaceutical Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Liabilities

Get a 7-Day Free Trial

4,518.21

2,800.14

2,728.60

2,102.89

2,008.42

Guizhou Xinbang Pharmaceutical Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Total Liabilities	Get a 7-Day Free Trial															1,954.73	1,926.66	1,799.70	2,008.42	2,015.63

Guizhou Xinbang Pharmaceutical Co Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Guizhou Xinbang Pharmaceutical Co's Total Liabilities for the fiscal year that ended in Dec. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	1806.874	+	(180.997	+	20.544
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0)
	=	2,008

Total Liabilities	=	Total Assets (A: Dec. 2024 )	-	Total Equity (A: Dec. 2024 )
	=	9028.336	-	7019.922
	=	2,008

Guizhou Xinbang Pharmaceutical Co's Total Liabilities for the quarter that ended in Mar. 2025 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	1746.788	+	(248.804	+	20.033
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0)
	=	2,016

Total Liabilities	=	Total Assets (Q: Mar. 2025 )	-	Total Equity (Q: Mar. 2025 )
	=	9016.153	-	7000.528
	=	2,016

Guizhou Xinbang Pharmaceutical Co Total Liabilities Related Terms

Thank you for viewing the detailed overview of Guizhou Xinbang Pharmaceutical Co's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Guizhou Xinbang Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Guizhou Xinbang Pharmaceutical Co Ltd (SZSE:002390) » Definitions » Total Liabilities

Traded in Other Exchanges

N/A

Address

6th Floor, Kekai 1st Court, Intersection of Aerospace Avenue and Xintian Avenue, Wudang District, Guiyang, CHN

Website

http://www.xinbang.com

Guizhou Xinbang Pharmaceutical Co Ltd is a China-based pharmaceutical company. The company is engaged in providing medical services and pharmaceutical distribution. The scope of business also covers the cultivation of Chinese herbal medicines, production of Chinese herbal medicines and Chinese patent medicines, research and development, production and sales of biological drugs, and other fields.

Executives

An Ji	Director
Gao Wen Lin	Executives
Lu Ya Fang	Executives
Xu Qi	Directors, executives
An Huai Lve	Director
Ma Cheng	Director
Zhang Jie Qing	Directors, executives
Kong Ling Zhong	Directors, executives
Liu Xiao Yang	Executives
Xiao Ya Yun	Executives
Yang Pei	Executives
Zhang Guan Fu	Director
Chen Chuan	Directors, executives
He Wen Jun	Supervisors
Lv Yu Tao	Director

Guizhou Xinbang Pharmaceutical Co Headlines

No Headlines